2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting
platelet aggregation and antagonizing thromboxane A.sub.2 therewith
    78.
    发明授权
    2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting platelet aggregation and antagonizing thromboxane A.sub.2 therewith 失效
    2-卤素取代的N-吲哚基乙基磺酰胺,并且抑制血小板聚集并拮抗血栓素A2

    公开(公告)号:US5015657A

    公开(公告)日:1991-05-14

    申请号:US436858

    申请日:1989-11-15

    CPC分类号: C07D209/30

    摘要: Inhibiting platelet aggregation and antagonizing thromboxane A.sub.2 with new 2-halogen-substituted N-indolyethyl-sulphonamides of the formula ##STR1## in which R.sup.1 represents hydrogen, halogen, trifluoromethyl, carboxyl or alkoxycarbonyl having up to 8 carbon atoms, orrepresents straight-chain or branched alkyl having up to 8 carbon atoms, or represents cycloalkyl having 3 to 8 carbon atoms, which is optionally substituted by carboxyl, halogen, alkoxy or alkoxycarbonyl having in each case up to 8 carbon atoms, cyano or hydroxyl, orrepresents a group of the formula --S(O).sub.n --R.sup.5,--NR.sup.6 R.sup.7 or --OR.sup.8represents straight-chain or branched alkyl having up to 10 carbon atoms, which is optionally substituted by halogen, phenyl, hydroxyl or cyano, orrepresents aryl having 6 to 10 carbon atoms, which is optionally substituted by up to 5 identical or different substituents from the group comprising halogen, cyano, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, alkyl, alkoxy, alkoxycarbonyl or alkylthio having in each case up to 8 carbon atoms, hydroxyl, carboxyl, phenyl, phenoxy, benzyloxy and benzylthio, or by a group of the formula --NR.sup.6 R.sup.7,R.sup.3 represents halogen,R.sup.4 represents hydrogen or straight-chain or branched alkyl having up to 8 carbon atoms, or represents phenylandm represents one of the numbers 2, 3 or 4, and salts thereof.

    摘要翻译: 抑制血小板聚集和拮抗血栓素A2与新的2-卤素取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N-取代的N- 具有至多8个碳原子的直链或支链烷基,或代表具有3-8个碳原子的环烷基,其任选被羧基,卤素,烷氧基或烷氧基羰基所取代,每种情况下最多具有8个碳原子,氰基或羟基,或 表示式-S(O)n -R 5,-NR 6 R 7或-OR 8表示具有至多10个碳原子的直链或支链烷基,其任选被卤素,苯基,羟基或氰基取代,或表示芳基 具有6至10个碳原子,其任选被至多5个相同或不同的取代基取代,所述取代基包括卤素,氰基,三氟甲基,三氟甲氧基,三氟甲硫基,烷基,烷氧基,烷氧基羰基或 具有至多8个碳原子的烷硫基,羟基,羧基,苯基,苯氧基,苄氧基和苄硫基,或由-NR 6 R 7基团,R 3表示卤素,R 4表示氢或具有直链或支链烷基的直链或支链烷基 8个碳原子,或表示苯基,m表示数2,3或4中的一个,及其盐。

    Cycloalkano(1,2-B) indole-sulponamides
    79.
    发明授权
    Cycloalkano(1,2-B) indole-sulponamides 失效
    环咯烷(1,2-B)吲哚磺胺

    公开(公告)号:US4988820A

    公开(公告)日:1991-01-29

    申请号:US556592

    申请日:1990-07-20

    摘要: Cycloalkano[1,2-b]indole-sulphonamides of the formula ##STR1## in which R.sup.1 represents hydrogen, halogen, trifluoromethyl, carboxyl or alkoxycarbonyl, represents a group of the formula --S(O).sub.m R.sup.3, in which R.sup.3 denotes alkyl or aryl, and m denotes one of the numbers 0, 1 or 2, represents a group of the formula ##STR2## in which R.sup.4 and R.sup.5 are identical or different and represent hydrogen, alkyl, aryl, aralkyl or acetyl, represents a group of the formula --OR.sup.6, in which R.sup.6 denotes hydrogen, alkyl, aryl, aralkyl, alkyl-SO.sub.2 --, aryl--SO.sub.2 --, aralkyl--SO.sub.2 -- or trifluoromethyl, or represents alkyl, alkenyl or cycloalkyl, each of which is optionally substituted by carboxyl, alkoxycarbonyl, halogen, hydroxyl, alkoxy, alkylthio or cyano, R.sup.2 represents aryl which is optionally substituted up to 5 times by halogen, cyano, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, alkyl, carboxyalkyl, alkoxycarbonylalkyl, alkoxy, alkylthio, hydroxyl, carboxyl, alkoxycarbonyl, phenyl, phenoxy, benzyloxy, benzylthio or a group of the formula ##STR3## in which R.sup.4 and R.sup.5 have the abovementioned meaning, x represents the number 1, 2 or 3, and y represents the number 0 or 1, where appropriate in an isomeric form, and their salts are disclosed. These compounds are useful to inhibit platelet aggregation and to antagonize thromboxane A.sub.2.

    摘要翻译: 其中R 1表示氢,卤素,三氟甲基,羧基或烷氧基羰基的式[IMAGE]的环烷基[1,2-b]吲哚磺酰胺代表式-S(O)m R 3的基团,其中R 3表示烷基或 芳基,m表示数字0,1或2中的一个,表示其中R 4和R 5相同或不同并且表示氢,烷基,芳基,芳烷基或乙酰基的式“IMAGE”的基团,表示 其中R 6表示氢,烷基,芳基,芳烷基,烷基-SO 2 - ,芳基-SO 2 - ,芳烷基-SO 2 - 或三氟甲基,或表示烷基,烯基或环烷基,其各自任选被羧基, 氰基,三氟甲基,三氟甲氧基,三氟甲硫基,烷基,羧基烷基,烷氧基羰基烷基,烷氧基,烷硫基,羟基,羧基,烷氧基羰基,烷氧基羰基,烷硫基, 苯基,苯氧基,苄氧基,苄硫基 或其中R 4和R 5具有上述含义的式“IMAGE”的基团,x表示数字1,2或3,并且y代表数字0或1,其中适当的是异构体形式,并且其公开的盐 。 这些化合物可用于抑制血小板聚集和拮抗血栓素A2。